Literature DB >> 400213

[Hemolysis after combined azathioprine and allopurinol therapy].

J Zazgornik, K Hruby, P Schmidt, H Kopsa, P Pils.   

Abstract

In a 37 year old renal transplant woman haemolytic anaemia was observed in the course of a combined azathioprine-allopurinol therapy. Azathioprine is converted to 6-mercaptopurine, which then catalyzed by xanthine oxidase is oxidized to 6-thiouric acid. When allopurinol and azathioprine are administered simultaneously, high 6-mercaptopurine concentrations in plasma may be expected because of inhibition of xanthine oxidase activity by allopurinol. We assume that elevated plasma 6-mercaptopurine concentration could possibly be responsible for haemolytic anaemia in this renal transplant patient.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 400213

Source DB:  PubMed          Journal:  Acta Med Austriaca        ISSN: 0303-8173


  3 in total

Review 1.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 2.  Use of allopurinol with low-dose 6-mercaptopurine in inflammatory bowel disease to achieve optimal active metabolite levels: a review of four cases and the literature.

Authors:  T N Witte; A L Ginsberg
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522

3.  Allopurinol influences aminophenazone elimination.

Authors:  M Barry; J Feely
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.